# Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism

> **NCT00452543** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 23 (actual)

## Conditions studied

- Major Depressive Disorder
- Alcohol Abuse
- Alcohol Dependence

## Interventions

- **DRUG:** acamprosate
- **DRUG:** escitalopram
- **BEHAVIORAL:** Medical management
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00452543
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2012-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00452543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00452543, "Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00452543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*